Oric Pharmaceuticals, Inc. (ORIC) Financials
ORIC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 254.7 million | 30.6 million |
2023-09-30 | 274.3 million | 26.9 million |
2023-06-30 | 291.8 million | 23.0 million |
2023-03-31 | 226.6 million | 23.8 million |
ORIC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -24.6 million | 3.9 million |
2023-09-30 | -19.7 million | 3.9 million |
2023-06-30 | -21.6 million | 3.8 million |
2023-03-31 | -20.9 million | 3.6 million |
ORIC Net Income
No data available :(
ORIC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 208.2 million | - | 2.8 million |
2023-09-30 | 227.3 million | - | 2.7 million |
2023-06-30 | 264.2 million | - | 2.7 million |
2023-03-31 | 189.6 million | - | 2.7 million |
ORIC Shares Outstanding
ORIC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 57000 | 24.5 million | 6.9 million | 263000 |
2023-09-30 | 77000 | 22.4 million | 6.3 million | - |
2023-06-30 | 405000 | 18.8 million | 6.2 million | - |
2023-03-31 | 310000 | 19.5 million | 6.2 million | - |
ORIC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 263000 |
2023-09-30 | - | 257000 |
2023-06-30 | - | 259000 |
2023-03-31 | - | 253000 |
ORIC
Price: $9.54
52 week price:
Earnings Per Share: -1.96 USD
P/E Ratio: -6.39
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 145300
Market Capitalization: 753.9 million